
Full INTerpath-001 results show the individualized mRNA therapy plus pembrolizumab reduced recurrence risk in resected stage IIB-IV melanoma.
Supplements and Featured Publications
In this AJMC® Profiles in Care, key stakeholders affiliated with Advocate Health Care in Southeast Chicago, Illinois share best practices for development of a limb salvage program for people at high risk of limb amputation due to peripheral artery disease.
almost 3 years ago
Inova Health System Center of Excellence





